Terms: = Colorectal cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43
46 results:
1. SIRT6 Inhibits Anoikis of colorectal cancer Cells by Down-Regulating ndrg1.
Li F; Yu W; Zhou X; Hou J; Gao Y; Zhang J; Gao X
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891773
[TBL] [Abstract] [Full Text] [Related]
2. Hypoxia-inducible factor 3α1 increases epithelial-to-mesenchymal transition and iron uptake to drive colorectal cancer liver metastasis.
Villareal LB; Falcon DM; Xie L; Xue X
Br J Cancer; 2024 Jun; 130(12):1904-1915. PubMed ID: 38693428
[TBL] [Abstract] [Full Text] [Related]
3. Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer.
Yang H; Xiao X; Zeng L; Zeng H; Zheng Y; Wang J; Li G; Dai W; He Y; Wang S; Peng J; Chen W
J Transl Med; 2024 Feb; 22(1):132. PubMed ID: 38310289
[TBL] [Abstract] [Full Text] [Related]
4. A review on the role of ndrg1 in different cancers.
Ghafouri-Fard S; Ahmadi Teshnizi S; Hussen BM; Taheri M; Sharifi G
Mol Biol Rep; 2023 Jul; 50(7):6251-6264. PubMed ID: 37249826
[TBL] [Abstract] [Full Text] [Related]
5. MicroRNA 483-3p overexpression unleashes invasive growth of metastatic colorectal cancer via ndrg1 downregulation and ensuing activation of the ERBB3/AKT axis.
Candiello E; Reato G; Verginelli F; Gambardella G; D Ambrosio A; Calandra N; Orzan F; Iuliano A; Albano R; Sassi F; Luraghi P; Comoglio PM; Bertotti A; Trusolino L; Boccaccio C
Mol Oncol; 2023 Jul; 17(7):1280-1301. PubMed ID: 36862005
[TBL] [Abstract] [Full Text] [Related]
6. Antitumor Activity of Piceamycin by Upregulation of N-Myc Downstream-Regulated Gene 1 in Human colorectal cancer Cells.
Kyaw KZ; Byun WS; Shin YH; Huynh TH; Lee JY; Bae ES; Park HJ; Oh DC; Lee SK
J Nat Prod; 2022 Dec; 85(12):2817-2827. PubMed ID: 36458922
[TBL] [Abstract] [Full Text] [Related]
7. colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution.
Chen G; Gong T; Wang Z; Wang Z; Lin X; Chen S; Sun C; Zhao W; Kong Y; Ai H; Yang H; Liu Y; Wu F; Kang J; Zhao S; Xiao X; Sun J; He A; Li Z
Cell Oncol (Dordr); 2022 Dec; 45(6):1155-1167. PubMed ID: 36136268
[TBL] [Abstract] [Full Text] [Related]
8. The Effects of Ovalbumin on Proliferation, Migration, and Stemness Properties of Chemoresistant SW480 Colon cancer Cells.
Monji H; Zand H; Ghorbani A; Pourvali K
Nutr Cancer; 2022; 74(10):3714-3722. PubMed ID: 35675283
[TBL] [Abstract] [Full Text] [Related]
9. Claudin-2 promotes colorectal cancer growth and metastasis by suppressing ndrg1 transcription.
Wei M; Zhang Y; Yang X; Ma P; Li Y; Wu Y; Chen X; Deng X; Yang T; Mao X; Qiu L; Meng W; Zhang B; Wang Z; Han J
Clin Transl Med; 2021 Dec; 11(12):e667. PubMed ID: 34965023
[TBL] [Abstract] [Full Text] [Related]
10. ndrg1 enhances the sensitivity of cetuximab by modulating EGFR trafficking in colorectal cancer.
Yang G; Huang L; Jia H; Aikemu B; Zhang S; Shao Y; Hong H; Yesseyeva G; Wang C; Li S; Sun J; Zheng M; Ma J
Oncogene; 2021 Oct; 40(41):5993-6006. PubMed ID: 34385595
[TBL] [Abstract] [Full Text] [Related]
11. ndrg1 regulates Filopodia-induced colorectal cancer invasiveness via modulating CDC42 activity.
Aikemu B; Shao Y; Yang G; Ma J; Zhang S; Yang X; Hong H; Yesseyeva G; Huang L; Jia H; Wang C; Zang L; Sun J; Zheng M
Int J Biol Sci; 2021; 17(7):1716-1730. PubMed ID: 33994856
[TBL] [Abstract] [Full Text] [Related]
12. A novel prognostic signature of immune-related genes for patients with colorectal cancer.
Wang J; Yu S; Chen G; Kang M; Jin X; Huang Y; Lin L; Wu D; Wang L; Chen J
J Cell Mol Med; 2020 Aug; 24(15):8491-8504. PubMed ID: 32564470
[TBL] [Abstract] [Full Text] [Related]
13. Blocking drug-induced autophagy with chloroquine in HCT-116 colon cancer cells enhances DC maturation and T cell responses induced by tumor cell lysate.
Zamame Ramirez JA; Romagnoli GG; Falasco BF; Gorgulho CM; Sanzochi Fogolin C; Dos Santos DC; Junior JPA; Lotze MT; Ureshino RP; Kaneno R
Int Immunopharmacol; 2020 Jul; 84():106495. PubMed ID: 32298965
[TBL] [Abstract] [Full Text] [Related]
14. N-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21.
Zhang S; Yu C; Yang X; Hong H; Lu J; Hu W; Hao X; Li S; Aikemu B; Yang G; He Z; Zhang L; Xue P; Cai Z; Ma J; Zang L; Feng B; Yuan F; Sun J; Zheng M
J Exp Clin Cancer Res; 2019 Dec; 38(1):490. PubMed ID: 31831018
[TBL] [Abstract] [Full Text] [Related]
15. Exosomes Derived from Human Primary and Metastatic colorectal cancer Cells Contribute to Functional Heterogeneity of Activated Fibroblasts by Reprogramming Their Proteome.
Rai A; Greening DW; Chen M; Xu R; Ji H; Simpson RJ
Proteomics; 2019 Apr; 19(8):e1800148. PubMed ID: 30582284
[TBL] [Abstract] [Full Text] [Related]
16. MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of ndrg1.
Liu J; Shao Y; He Y; Ning K; Cui X; Liu F; Wang Z; Li F
Cancer Sci; 2019 Jan; 110(1):135-146. PubMed ID: 30407715
[TBL] [Abstract] [Full Text] [Related]
17. The prognostic value of decreased ndrg1 expression in patients with digestive system cancers: A meta-analysis.
Chen K; Liu XH; Wang FR; Liu HP; Huang ZP; Chen X
Medicine (Baltimore); 2018 Oct; 97(41):e12455. PubMed ID: 30313035
[TBL] [Abstract] [Full Text] [Related]
18. A combined literature and in silico analysis enlightens the role of the NDRG family in the gut.
Vaes N; Schonkeren SL; Brosens E; Koch A; McCann CJ; Thapar N; Hofstra RMW; van Engeland M; Melotte V
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2140-2151. PubMed ID: 30033230
[TBL] [Abstract] [Full Text] [Related]
19. Identification of genes inducing resistance to ionizing radiation in human rectal cancer cell lines: re-sensitization of radio-resistant rectal cancer cells through down regulating ndrg1.
Kim SC; Shin YK; Kim YA; Jang SG; Ku JL
BMC Cancer; 2018 May; 18(1):594. PubMed ID: 29801473
[TBL] [Abstract] [Full Text] [Related]
20. N-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2.
Yang X; Zhu F; Yu C; Lu J; Zhang L; Lv Y; Sun J; Zheng M
Oncotarget; 2017 Jul; 8(29):47709-47724. PubMed ID: 28537875
[TBL] [Abstract] [Full Text] [Related]
[Next]
